Directors of the California stem cell agency last week handed out $2 million a minute to nearly 20 organizations during an online meeting that spread the largess from Sacramento in the north to San Diego in the south.
All but one of the awards went to institutions that have or had ties to members of the governing board of what is known officially as the California Institute for Regenerative Medicine (CIRM).Its total cost to taxpayers is estimated to be about $12 billion.
The situation is nothing new for CIRM, which was designed in 2004 to give nearly all the Golden States stem cell research organizations a seat at the table where the money is handed out.
In slightly more than 47 minutes, the directors rubber-stamped the earlier de facto decisions on the $98 million in grant applications
Since CIRMs inception, 80 percent of the awards $2.7 billion has gone to organizations with links to board members,according to an analysis by theCalifornia Stem Cell Report. And it is all legal, courtesy of the states ballot initiative process.
Last weeks session involved training grants for graduate students. A few years back the program was terminated because of a lack of funds. CIRM shifted its emphasis to clinical trials. But with the infusion of $5.5 billion from Proposition 14 last fall,the trainingprogram was resurrected.
Directors of the agency are solidly behind what is known as the CIRM Scholars training program. CIRM DirectorDavid Martin, CEO of the biotech companyAvidBiotics, said during last Thursdays meeting that he considered the agencys training programs as the biggest legacy that CIRM will have because of the enduring influence of the young scientists that it is supporting.
Seventeen of 18 training awards went to institutions with links to current or past directors of the agency. All of the organizations that applied received about $5 million each with the exception ofUC Santa Barbarawhich applied for only $1.9 million. A $12 million clinical trial award was made to a Stanford researcher.
In slightly more than 47 minutes, the directors last Thursday rubber-stamped the earlier de facto decisions on the $98 million in grant applications made by anonymous reviewers who met in private. The reviewers also do not have to publicly disclose their financial, professional or personal conflicts of interest.
CIRM board members, however, are required to disclose the outlines of their financial interests. They are not allowed to vote on applications for which they have a legal, financial conflict of interest. Nor do board members, at their award ratification meetings, see the full applications. Only reviewers and CIRM staff have access to those.
(For a look at the process used by directors, see this piece:What is a California ARS? And How Can It Give Away Billions of Dollars?)
Summaries of the reviews are prepared by the staff, however, and often contain illuminating details. The application with the highest score 98 came fromUC Irvine.Peter Donovan at the Orange County campusprepared the application and heads the program. Reviewers were effusive: An excellent proposal in every way almost perfect.
The review summary said,
They have used their experience with prior CIRM training support and (federal)NIH T32 supportto provide meaningful direction to guide the current program. This includes: a focus on mentorship as a key pillar of training; a focus on soft skills in the education of trainees (communication, conflict resolution, management, and skills development); and active involvement of clinical colleagues; a focus on translational research; and increased community engagement and outreach.
(All of the review summaries can be found here.The names of the institutions and personal applicants are not on the summaries. Search them using the application numbers found below.)
One of the recipients has never received major funding from CIRM: theLundquist Instituteof Torrance, Ca., which says14 companies have spun off from research that it has helped to support over the last 12 years.
The clinical trial research awardwent toMaria Grazia Roncaroloof Stanford. (Her review summary can befound here.) The award represents CIRMs 76th clinical tria and involves a potential treatment for a form of pediatric cancer.
Here is the list of CIRM Scholar Training Program awards with the application numbers following the name of the recipient.
Clive Svendsen, EDUC4-12751,Cedars-Sinai,CIRM Training Program in Translational Regenerative Medicine
Prue Talbot, EDUC4-12752,UC Riverside,TRANSCEND Training Program to Advance Interdisciplinary Stem Cell Research, Education, and Workforce Diversity
William Lowry, EDUC4-12753,UCLA,UCLA Training Program in Stem Cell Biology
Gage DeKoeyer Crump, EDUC4-12756,University of Southern California,Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine
Camilla Forsberg,EDUC4-12759,UC Santa Cruz,CIRM Training Program in Systems Biology of Stem Cells
Bruce Conklin, EDUC4-12766,Gladstone Institute,CIRM Regenerative Medicine Research Training Program
Michael Barish, EDUC4-12772,City of Hope,Research Training Program in Stem Cell Biology and Regenerative Medicine
Michael Longaker, EDUC4-12782,Stanford,CIRM Scholar Training Program
Dick Hockemeyer, EDUC4-12790,UC Berkeley,Training the Next Generation of Biologists and Engineers for Regenerative Medicine
Jan Nolta, EDUC4-12792,UC Davis,CIRM Cell and Gene Therapy Training Program 2.0
Ching-Ling Lien, EDUC4-12802,Childrens Hospital of Los Angeles,CIRM Training Program for Stem Cell and Regenerative Medicine Research
Alysson Muotri, EDUC4-12804,UC San Diego,Interdisciplinary Stem Cell Training Grant at UCSD III
Peter Schultz, EDUC4-1281,Scripps Research Institute,Training Scholars in Regenerative Medicine and Stem Cell Research
Robert Blelloch, EDUC4-12812,UC San Francisco,Scholars Research Training Program in Regenerative Medicine, Gene Therapy, and Stem Cell Research
Evan Snyder, EDUC4-12813,Sanford Burnham,A Multidisciplinary Stem Cell Training Program at Sanford Burnham Prebys Institute, A Critical Component of the La Jolla Mesa Educational Network
Dennis Clegg, EDUC4-12821,UC Santa Barbara,CIRM Training Program in Stem Cell Biology and Engineering
Peter Donovan, EDUC4-12822,UC Irvine,CIRM Scholars Comprehensive Research Training Program
Virender Rehan, EDUC4-12837,Lundquist Institute for Biomedical Innovation,Stem Cell Training Program at the Lundquist Institute
Here is a link tothe CIRM news releaseabout the awards.Editors Note: David Jensen is a retired newsman who has covered the state stem cell agency since it was approved by voters in 2004.
Want to see more stories like this? Sign up for The Roundup, the free daily newsletter about California politics from the editors of Capitol Weekly. Stay up to date on the news you need to know.
Sign up below, then look for a confirmation email in your inbox.
Read the original:
Stem cell agency gives out $2 million a minute - Capitol Weekly
- World's first diabetes cure with cell therapy achieved in China - Interesting Engineering - May 27th, 2024
- Illustration of stress buildup [IMAGE] - EurekAlert - May 27th, 2024
- U.S. Induced Pluripotent Stem Cell (iPSC) Market Anticipated to Climb to USD 1,372.22 Million by 2032, with... - WhaTech - May 25th, 2024
- City of Hope Awarded $5.4 Million CIRM Grant to Create a Stem Cell Laboratory and Expand Access to State-of-the-Art ... - Elk Valley Times - May 25th, 2024
- Aspen wins grant to advance stem cell therapy for Parkinson's disease - Parkinson's News Today - May 23rd, 2024
- Fort Lauderdale woman says she paid over $14K for stem cell injections that did not cure arthritis - WSVN 7News | Miami News, Weather, Sports | Fort... - May 23rd, 2024
- Benefits of Stem Cell Therapy: Unlocking Regenerative Medicine's Potential - Intelligent Living - May 23rd, 2024
- The rapid progression of sepsi [IMAGE] - EurekAlert - May 18th, 2024
- Sketchy stem-cell treatments in Mexico led to drug-resistant infections - Livescience.com - May 15th, 2024
- Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 1 In-Process ... - BioProcess Insider - May 15th, 2024
- Innovative 'mini-brains' could revolutionize Alzheimer's diagnosis and treatment - News-Medical.Net - May 15th, 2024
- Cell Therapy Market size is set to grow by USD 31041.49 million from 2023-2027, limitations in traditional organ ... - The Malaysian Reserve - May 15th, 2024
- Notes from the Field: Potential Outbreak of Extrapulmonary ... - CDC - May 13th, 2024
- Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem Cell ... - Yale School of Medicine - May 10th, 2024
- Stem Cell Therapy Improves Post-Stroke Motor Function - Medscape - May 10th, 2024
- Ozzy Osbourne receiving stem cell treatments amid health problems - The Star Online - May 10th, 2024
- How hematopoietic stem cells retain their regenerative potential - Drug Target Review - May 10th, 2024
- First Patient Begins Newly Approved Sickle Cell Gene Therapy - The New York Times - May 8th, 2024
- Advances and challenges of the cell-based therapies among diabetic patients - Journal of Translational Medicine - Journal of Translational Medicine - May 8th, 2024
- Stem Cell Therapy market impeccable growth with a CAGR of 18.9% during 2023-2029 - openPR - May 8th, 2024
- Stem Cells market to be at USD 5673.4 million by 2029 with a CAGR of 10.4% during 2023-2029 - openPR - May 8th, 2024
- "Charting the Course: Global Animal Stem Cell Therapy Market - openPR - May 8th, 2024
- Stanford stem cell researcher who discovered how to regrow cartilage, dies at 48 - Redwood City Pulse - May 6th, 2024
- Chuck Chan, stem cell researcher who discovered how to regrow cartilage, dies at 48 - Palo Alto Online - May 4th, 2024
- Stem Cell and Platelet Rich Plasma Alopecia Therapies Market Analysis and Future Outlook by 2030 - openPR - May 4th, 2024
- Opinion: As stem cell biologists, we're concerned a Utah law will lead to a boom in snake oil sales - Salt Lake Tribune - May 2nd, 2024
- Robert Hariri: Developing Cost-Effective Cell Therapies From Placentas - BioSpace - May 2nd, 2024
- USC-led study introduces a new and improved way to grow the cells that give rise to the kidney's filtration system - EurekAlert - May 2nd, 2024
- Using stem cell-derived heart muscle cells to advance heart regenerative therapy - Medical Xpress - April 28th, 2024
- John Cleese is spending thousands on stem cell therapy is it really the secret to anti-ageing? - Yahoo Lifestyle Australia - April 28th, 2024
- SUM Hospital conducts Odishas first stem cell transplantation - The Times of India - April 24th, 2024
- Cancer treatment: What is stem cell therapy, and how does it work? - Moneycontrol - April 24th, 2024
- The murky, unregulated world of anti-ageing stem cell therapy - The Telegraph - April 24th, 2024
- Drug Prototype Promising in Treatment of Pulmonary Disease - Medscape - April 20th, 2024
- Man Paralyzed In Surfing Accident Regains Ability to Walk After Stem Cell Treatment - The Inertia - April 20th, 2024
- Medical breakthrough: 8-year-old boy first in New York to receive FDA-approved gene therapy for rare inherited blood disorder - WABC-TV - April 20th, 2024
- Stem Cell Treatment Helped A Man Who Was Paralyzed From The Neck Down To Stand On His Own - Bored Panda - April 20th, 2024
- UM, CUHK jointly hold symposium on stem cells and regenerative medicine - gcs.gov.mo - April 20th, 2024
- Paralysed patient now able to walk as stem cell therapy shows promising results - WION - April 15th, 2024
- Andrew Steele Sees Aging as the Root of Disease - Worth - Worth Magazine - April 15th, 2024
- The astonishing effect of stem cell implants - as groundbreaking treatment 'transforms' life for those with brain damage ... - Daily Mail - April 15th, 2024
- Consumer Alert on Regenerative Medicine Products Including Stem Cells - FDA.gov - April 13th, 2024
- This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market - Forbes - April 13th, 2024
- Brain-cell transplants are the newest experimental epilepsy treatment - MIT Technology Review - April 3rd, 2024
- Global Regenerative Medicine Market to Touch Valuation of USD 472.95 Billion by 2032, at 25.86% CAGR: Astute ... - Yahoo Finance - April 1st, 2024
- Explosive Growth Projected for Stem Cell Market, Expected to Surpass $37 Billion by 2030 As Revealed In New... - WhaTech - April 1st, 2024
- Integrating New Therapies With Autologous Stem Cell Transplant in Myeloma - Targeted Oncology - April 1st, 2024
- New tool provides researchers with improved understanding of stem cell aging in the brain - Medical Xpress - March 30th, 2024
- The ISSCR announces 2024 election results - EurekAlert - March 28th, 2024
- Exosomes and Stem Cells Are the Future of Anti-Aging - NewBeauty Magazine - March 28th, 2024
- Charles River Extends Gene Therapy Alliance with NUS Medicine - Contract Pharma - March 22nd, 2024
- Exciting opportunities in stem cell technology and regenerative biology in Indian healthcare industry - Express Healthcare - March 22nd, 2024
- Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine - Yahoo Finance - March 22nd, 2024
- Opinion: The revolutionary sickle cell therapies - MSN - March 22nd, 2024
- 10 Years of Kansas Regenerative Medicine Center - KSAL - March 22nd, 2024
- BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership - Diagnostic and Interventional Cardiology - March 17th, 2024
- Cynata Therapeutics' breakthrough in regenerative medicine - Finance News Network - March 17th, 2024
- New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia - GlobeNewswire - March 17th, 2024
- Novel 3D stem cell therapy to treat critical limb ischaemia - Drug Target Review - March 15th, 2024
- Breaking Boundaries: Pharmicell's Bold Vision for Healthcare Transformation and Monumental Growth - The Worldfolio - March 15th, 2024
- CuSTOM Organoid Research Evolving From Tool to Treatment - Research Horizons - Research Horizons - March 15th, 2024
- BioCardia and StemCardia Announce Partnership to Deliver Cell-Gene Therapy for Remuscularization of Heart - Cath Lab Digest - March 15th, 2024
- Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine ... - Business Wire - March 13th, 2024
- Iron restriction keeps blood stem cells young, researchers find - Phys.org - March 13th, 2024
- Vitamin A could have a key role in both stem cell biology and wound healing: Study - Medical Dialogues - March 9th, 2024
- Trends in Stem Cell Transplantation Refusal for Myeloma Treatment - Targeted Oncology - March 7th, 2024
- Stem Cell Therapy Market (CAGR) of 31.1%, Future of Market Size Emerging Technologies and their Impact on ... - Taiwan News - March 7th, 2024
- This Swedish startup wants to reduce the cost, and controversy, around stem cell production - TechCrunch - March 6th, 2024
- Advancing stem cell therapy: The regulatory process to get to clinical trials - The Economic Times - March 6th, 2024
- Transitioning from traditional surgical methods to the innovative use of stem cells - pharmaphorum - March 6th, 2024
- 'Mini organs' are grown from human stem cells taken during the late stages of pregnancy for the first time - m - Daily Mail - March 6th, 2024
- Stem cell transplant cures man of HIV and leukemia, one of five to achieve full remission - Fox 28 - March 3rd, 2024
- Stem Cell Therapy Market to Boost USD 137.5 Billion by 2034 and Projected to grow at 32.10% CAGR with increasing ... - Yahoo Finance - March 1st, 2024
- Studies expand use of stem cell therapies - WPLG Local 10 - March 1st, 2024
- Innovative therapy targets and destroys leukemia stem cells - News-Medical.Net - February 27th, 2024
- Unlocking the Potential of Stem Cells: The Medical Revolution of the Century - EIN News - February 27th, 2024
- Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine ... - Yahoo Finance - February 27th, 2024
- Say Her Name - Henrietta Lacks, The Real Mother Of Stem - Her Campus - February 27th, 2024
- California Man Free of HIV And Cancer in Astonishing Medical Recovery - ScienceAlert - February 25th, 2024
- $93 million for research into improved health for children, young people and the aged, medical devices, mental health ... - Department of Health - February 25th, 2024
Recent Comments